You are here

breast cancer

FDA Approves Truqap Plus Faslodex for Advanced HR-Positive Breast Cancer

Pharm Exec

Fri, 11/17/23 - 10:09 am

Olema scores in Phase II breast cancer trial with Phase III dosing in weeks

Clinical Trials Arena

Mon, 10/23/23 - 09:10 am

clinical tirals

Seagen wins future royalties in Enhertu patent dispute

Pharmaphorum

Wed, 10/18/23 - 10:07 am

BioNTech takes another leaf out of Daiichi playbook, paying $70M for HER3-directed ADC

Fierce Biotech

Thu, 10/12/23 - 10:07 am

antibody-drug conjugate

Daiichi Sankyo reports positive results from trial of breast cancer therapy

Clinical Trials Arena

Mon, 09/25/23 - 11:47 am

clinical trials

AstraZeneca, Daiichi Tout Phase III Breast Cancer Data in Challenge to Gilead

BioSpace

Fri, 09/22/23 - 11:51 am

antibody-drug conjugate

clinical trials

Seagen’s breast cancer therapy meets main goal in late-stage study

Medical Marketing and Media

Wed, 08/16/23 - 11:34 pm

clinical trials

Merck's Keytruda meets main goal in late-stage breast cancer study

Reuters

Sat, 07/29/23 - 10:40 pm

clinical trials

ASCO in Review: Oncologists See Practice-Changing, Affirming Data

BioSpace

Thu, 06/8/23 - 09:26 pm

non-small cell lung cancer

Moderna Therapeutics

Burning Rock's precision oncology diagnostics product supports advancement in late-stage breast cancer treatment

BioSpace

Thu, 06/8/23 - 09:50 am

Burning Rock Biotech

genomic profiling

OncoScreen Plus

Novartis drug helps stop breast cancer’s return in large study

BioPharma Dive

Fri, 06/2/23 - 11:24 am

clinical trials

Byondis' breast cancer drug fails to bloom as FDA denies approval

Fierce Biotech

Tue, 05/16/23 - 10:27 pm

antibody-drug conjugate

HER-2 positive breast cancer

Roche, with HER2 franchise under pressure, pays $70M for breast cancer brain metastases prospect

Fierce Biotech

Tue, 05/9/23 - 11:39 am

brain metastases

Roche nixes Tecentriq trial in early breast cancer, but it's 'still in the game' in key lung cancer use: exec

Fierce Pharma

Wed, 04/26/23 - 10:12 am

OncoRix's breast cancer integrative solution demonstrated enhanced efficacy when combined with chemotherapy in an ex-vivo model

BioSpace

Fri, 03/31/23 - 10:33 am

Novartis' Kisqali cuts recurrence risk in early-stage breast cancer

BioSpace

Mon, 03/27/23 - 11:27 am

clinical trials

Olema Oncology to cut 25% of staff, says it will focus on late-stage pipeline

Endpoints

Fri, 03/10/23 - 09:49 am

FDA widens Lilly's Verzenio breast cancer reach, removes test and menopausal status demands

Fierce Pharma

Mon, 03/6/23 - 11:50 am

Aileron Terminates Phase 1b Breast Cancer Chemoprotection Trial Of ALRN-6924

NASDAQ

Tue, 02/21/23 - 04:34 pm

Aileron Therapeutics

clinical trials

Next phase of breast cancer vaccine research begins at Cleveland Clinic

WKYC

Thu, 02/9/23 - 10:31 am

Cleveland Clinic

triple negative breast cancer

Pages